The World Health Organization (WHO) this week published two reports spotlighting gaps in adequate medicines and diagnostic ...

Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

The WHO’s new reports on invasive fungal infections highlight the urgent need for global action to address the critical ...

The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and diagnostic tools for invasive fungal diseases, showing the urgent need for ...

The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is ...

Mandimycin targets fungi using a surprising mechanistic ... family of glycosylated polyene macrolides that has provided many antifungal drugs, including AmB, nystatin and natamycin.

Scientists have identified strains of one of the world's most dangerous fungal pathogens, already resistant to our most effective antifungal drugs, which are also five times more likely to acquire ...